Breaking News Instant updates and real-time market news.

TSLA

Tesla

$356.05

0.01 (0.00%)

, HD

Home Depot

$193.52

-0.59 (-0.30%)

11:58
08/14/18
08/14
11:58
08/14/18
11:58

Fly Intel: Wall Street's top stories at midday

Stocks opened higher as concerns surrounding the Turkish economic crisis eased overnight. The averages opened in positive territory and lost most of their gains in the opening 30 minutes before reversing and moving back to session highs. The move is broad based as each of the major equity indices is higher by roughly 0.4%. Oil prices have bounced back as well with crude sporting a gain of 0.3%, but off its best levels from earlier. ECONOMIC NEWS: In the U.S., the July NFIB small business optimism index moved up 0.7 ticks to 107.9, another record high. U.S. chain store sales fell 1.2% in the week ended August 11, according to The Retail Economist report, largely reversing the 1.4% bounce in the August 4 week. July import prices in the U.S. were flat and export prices fell 0.5%, weaker than analysts expected. COMPANY NEWS: Tesla (TSLA) confirmed this morning that the car maker's board of directors has formed a special committee comprised of three independent directors to act on behalf of the company in connection with Elon Musk's previously announced consideration of a transaction to take the company private. The committee has not yet received a formal proposal from Musk regarding any transaction nor has it reached any conclusion as to the advisability or feasibility of such a move, Tesla noted... Meanwhile, Home Depot (HD) was in focus after the home improvement retailer reported better-than expected results for the second quarter and raised its fiscal 2018 earnings per share guidance. Of note, the company said on its quarterly earnings conference call that the current tariff environment is "manageable" and that it sees $6B of share repurchases in FY18... Additionally, shares of Tapestry (TPR) jumped over 12% after the company, previously known as Coach, reported better than expected fourth quarter results, driven by strong performance of its Kate Spade business. MAJOR MOVERS: Among the noteworthy gainers was SJW Group (SJW), which rose 5.2% after California Water Service Group (CWT) submitted a revised proposal to acquire all outstanding shares of SJW for $70 per share in cash. Also higher was Advance Auto Parts (AAP), which gained 7.2% after reporting quarterly results. Among the notable losers was Vipshop (VIPS), which slipped nearly 15% after Citi analyst Alicia Yap downgraded the stock to Sell from Buy and cut her price target to $8 from $17, citing declining margins and decelerating growth. Also lower were Switch (SWCH) and Alta Mesa Resources (AMR), which fell a respective 24.5% and 19% after reporting quarterly results. INDEXES: At midday, the Dow was up 83.67, or 0.33%, to 25,271.37, the Nasdaq was up 43.61, or 0.56%, to 7,863.49, and the S&P 500 was up 17.29, or 0.61%, to 2,839.25.

TSLA

Tesla

$356.05

0.01 (0.00%)

HD

Home Depot

$193.52

-0.59 (-0.30%)

TPR

Tapestry

$52.87

5.45 (11.49%)

SJW

SJW Corp.

$65.74

3.25 (5.20%)

CWT

California Water Service

$40.25

0.2 (0.50%)

AAP

Advance Auto Parts

$155.57

10.78 (7.45%)

VIPS

Vipshop

$7.69

-1.29 (-14.37%)

SWCH

Switch

$10.62

-3.34 (-23.93%)

AMR

Alta Mesa Resources

$4.98

-1.1 (-18.09%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 10

    Sep

  • 12

    Sep

  • 29

    Oct

TSLA Tesla
$356.05

0.01 (0.00%)

08/08/18
RBCM
08/08/18
NO CHANGE
Target $110
RBCM
Outperform
RBC Capital revisits idea of Celgene going private after Tesla proposal
Following yesterday's news that Tesla (TSLA) CEO Elon Musk would like to see his company go private, RBC analyst Brian Abrahams revisited his prior analysis of whether Celgene (CELG) should go private in order to better capture the medium-term value of future Revlimid cash flows not being appreciated by public markets and avoid volatility as it transitions to a post-Revlimid business model. Though acknowledging that the two companies are in completely different industries, he thinks the example of Musk shows that performing such a transaction on a large company "may not be completely unrealistic," Abrahams said. Such an LBO, or perhaps more likely an acquisition by a larger pharmaceutical company, could possibly help capture more value from Celgene's commercial and pipeline products, concludes Abrahams, who has an Outperform rating and $110 price target on Celgene shares.
08/10/18
MSCO
08/10/18
NO CHANGE
Target $291
MSCO
Equal Weight
Morgan Stanley says Tesla LBO doesn't seem feasible, equity buyout might be
Morgan Stanley analyst Adam Jonas said a leveraged buyout, or LBO, of Tesla does not appear to be feasible, even with less than $10B of incremental debt. However, he believes Tesla could consider an auction for its shares in the private equity market, financed by existing shareholders, new strategic investors, the possible divestiture of assets such as Tesla's autonomous and shared mobility assets and "possibly some help from SpaceX." However, Jonas notes that he has no knowledge of an equity buyout, or EBO, being considered by the company. He maintains an Equal Weight rating and $291 price target on Tesla shares.
08/08/18
08/08/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. REACTIONS TO TESLA'S TALK OF GOING PRIVATE: Jefferies analyst Philippe Houchois raised his price target for Tesla (TSLA) to $360 from $250 after CEO Elon Musk suggested taking the company private. Going private "feels like the right thing to do," Houchois said. "Distraction or not, the move feels right even if Musk is downplaying how supportive public markets have been," the analyst adds. However, with Tesla unable to take on more debt, Houchois wondered who may fund the potential deal and end up as a new large shareholder. While Morgan Stanley analyst Adam Jonas sympathizes with Elon Musk's argument that Tesla could be better off as a private company, he questioned the feasibility of Musk actually being able to achieve that goal. Taking the company private would assume either that the company is on the verge of generating self-sustaining cash flows or that it can tap into a range of strategic sources of capital not previously at its disposal, said Jonas, who sees strategic value at Tesla but thinks the "LBO math required to support [a price of] $420 is extremely aggressive." MORGAN STANLEY SAYS SOUTHWEST A GOOD FIT FOR BERKSHIRE: Morgan Stanley analyst Kai Pan noted that Berkshire Hathaway (BRK.A) has shifted tone in recent years and become a top three shareholder of the "Big Four" U.S. airlines, including Southwest (LUV). Media reports from Forbes, CNN and others have discussed a possible acquisition by Berkshire of the airline, added Pan. He analyzed a theoretical acquisition and came to the conclusion that Southwest could be a strategic fit for Berkshire and the advantages could also be compelling for the airline. Pan estimates Berkshire could pay a 20-40% premium, or $70-80 per share for Southwest, in such a hypothetical takeover situation. Pan has an Overweight rating and $67 price target on Southwest shares. BARCLAYS POSITIVE ON SNAP GUIDANCE CHANGE: Barclays analyst Ross Sandler views Snap's (SNAP) Q2 results as a "mixed bag," with daily active users 2M below his estimate and revenue $20M above his estimate. More importantly, the change in approach towards guidance is "very welcomed and should help to reduce some of the volatility going forward," Sandler said. He believes this is a "big positive for long-term holders looking to get involved." The analyst kept an Overweight rating on Snap with a $16 price target. WAINWRIGHT SAYS INSMED LIKELY TO BE ACQUIRED: H.C. Wainwright analyst Andrew Fein raised his price target for Insmed (INSM) to $43 from $35 following the 12-2 FDA panel vote in favor of ALIS in refractory nontuberculous mycobacterial patients. Insmed is now likely to be acquired as ALIS "fits well within the pipeline of a number of larger companies," Fein said.
08/08/18
BARD
08/08/18
NO CHANGE
Target $411
BARD
Outperform
Tesla $420 buyout price mentioned by Musk too low, says Baird
Baird analyst Ben Kallo believes the Tesla buyout price of $420 mentioned by Elon Musk is too low. He expects the shares to trade above that mark as investors will demand a higher premium, which will coincide with short covering. Kallo reiterated his Outperform rating and $411 price target on Tesla shares.
HD Home Depot
$193.52

-0.59 (-0.30%)

07/27/18
BARD
07/27/18
NO CHANGE
BARD
GDP report included encouraging data for home improvement retailers, says Baird
Baird analyst Peter Benedict said that the Q2 GDP report included a few encouraging data points on housing that reinforced his positive near- and long-term view on Home Depot (HD) and Lowe's (LOW). Specifically, he points out that growth in private residential investment accelerated to 7.4%year-over-year. Benedict noted that changes in PRI and home center comps have a "strong historical correlation." He also noted that household formation accelerated to an annualized pace of 1.7M in Q2 from about a 1.2M rate in Q1. Benedict has Overweight ratings on both Home Depot and Lowe's.
08/03/18
PIPR
08/03/18
DOWNGRADE
Target $39
PIPR
Neutral
Floor & Decor downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Peter Keith downgraded Floor & Decor (FND) to Neutral and lowered his price target for the shares to $39 from $58. The analyst, who admits his June upgrade of the stock was wrong, highlights Luxury Vinyl Tile's disruptive nature on the industry and Home Depot's (HD) "strong share gains" in flooring following Floor & Decor's Q2 miss and guide down. The quarter suggests the impact of these dynamics is occurring faster than anticipated, Keith tells investors in a research note. JPMorgan this morning also downgraded Floor & Decor.
08/14/18
GSCO
08/14/18
NO CHANGE
GSCO
Neutral
Home Depot 2H deceleration as expected, says Goldman Sachs
Goldman Sachs analyst Matthew Fassler said Neutral rated Home Depot reported a solid Q2 beat and guided to a 2H 2018 deceleration against tougher storm-driven comps. Fassler expects the stock to have an in-line reaction to the print and said the read through for Lowe's (LOW) suggests an in-line report with his forecast.
08/10/18
OPCO
08/10/18
NO CHANGE
Target $220
OPCO
Outperform
Home Depot price target raised to $220 from $205 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target on Home Depot to $220 from $205 ahead of the company's Q2 earnings report, citing his continued confidence in the potential for Home Depot to capitalize on favorable demand dynamics in the home improvement space. In a research note to investors, Nagel said he remains bullish and looks towards the Q2 results as a potential near-term positive catalyst for shares. Nagel has an Outperform rating on Home Depot.
TPR Tapestry
$52.87

5.45 (11.49%)

07/31/18
UBSW
07/31/18
NO CHANGE
Target $59
UBSW
Buy
Tapestry price target lowered to $59 from $62 at UBS
UBS analyst Jay Sole said one of the main tenets of his buy thesis on Tapestry was that a product shift mix will lead to more full price selling. He recent research has led him to begin to doubt that will occur so he lowered his estimates and price target to reflect it. Sole said he still sees a favorable risk/reward for Tapestry and reiterated his Buy rating while lowering his target to $59 from $62.
07/09/18
WELS
07/09/18
NO CHANGE
Target $56
WELS
Outperform
Tapestry fundamental story intact, guidance likely near-term issue, says Wells Fargo
Wells Fargo analyst Ike Boruchow remains bullish on the Tapestry story and reiterates the name as one of his top idea as he has gained greater confidence in both the Kate Spade turnaround efforts, as well as the trajectory of Coach brand. That said, the analyst does see some headwinds to next full year that the Street does not appear to be modeling, leading him to cut his FY19 EPS as he believes guidance is likely a near-term issue. Boruchow reiterates an Outperform rating and $56 price target on the shares.
06/25/18
GSCO
06/25/18
INITIATION
GSCO
Sell
PVH Corp. initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated PVH Corp (PVH) with a Sell, telling investors in a research note that while the company has benefited from a strong acceleration in growth in Tommy Hilfiger and Calvin Klein, she believes momentum is peaking as a number of tailwinds fade. This morning, Walvis also initiated shares of Tapestry (TPR) with a Conviction Buy and Tiffany (TIF) and VFC (VFC) with a Buy.
08/14/18
LOOP
08/14/18
NO CHANGE
Target $59
LOOP
Buy
Loop Capital would continue buying shares of Tapestry
Loop Capital analyst Laura Champine reiterates a Buy rating on Tapestry with a $59 price target following this morning's Q4 results. The analyst is "pleased" with in-line June quarter sales at Coach and upside at Kate Spade. The analyst expects the long-term cost synergies from the Kate Spade deal "to be substantial" and would continue buying shares of Tapestry. The stock in morning trading is up 10.5%, or $4.98, to $52.44.
SJW SJW Corp.
$65.74

3.25 (5.20%)

04/26/18
JANY
04/26/18
DOWNGRADE
JANY
Neutral
SJW Corp. downgraded to Neutral from Buy at Janney Capital
Janney Capital cited SJW Group (SJW) valuation after California Water Service Group (CWT) confirmed that it proposed to acquire SJW for $68.25 per share. Subsequently, SJW rejected Cal Water's offer, having determined that it was not a superior proposal as defined in SJW's merger agreement with Connecticut Water Service (CTWS).
CWT California Water Service
$40.25

0.2 (0.50%)

03/08/18
UBSW
03/08/18
INITIATION
Target $34
UBSW
Sell
California Water Service initiated with a Sell at UBS
UBS analyst Daniel Ford started California Water Service with a Sell rating and $34 price target. The analyst believes the regulatory climate in California has declined over the past twelve months.
03/26/18
HDLY
03/26/18
UPGRADE
HDLY
Neutral
California Water Service upgraded to Neutral from Underperform at Hilliard Lyons
Hilliard Lyons analyst Spencer Joyce upgraded California Water Service to Neutral from Underperform as he believes Cal Water's revised Cost of Capital ruling removes a lingering negative catalyst and given what he sees as a "rising affinity" for the Utilities sector.
04/02/18
WELS
04/02/18
UPGRADE
Target $35
WELS
Market Perform
California Water Service upgraded to Market Perform from Underperform at Wells Fargo
Wells Fargo analyst Jonathan Reeder upgraded California Water Service to Market Perform from Underperform and raised his price target to $35 from $34. The analyst cites a more favorable valuation on the stock followings its 21% year-to-date decline as well as the cost of capital decision by the state of California being in the past. Reeder adds that the company's annualized EPS growth rate, which he sees as achievable, is "at least commensurate" with its peers.
AAP Advance Auto Parts
$155.57

10.78 (7.45%)

07/06/18
ARGS
07/06/18
NO CHANGE
Target $155
ARGS
Buy
Advance Auto Parts price target raised to $155 from $135 at Argus
Argus analyst Christopher Graja raised his price target on Advance Auto Parts to $155 and also raised his FY19 EPS target to $7.90 from $7.50, saying he is now modeling an 80bps improvement in operating margins thanks to the company's efforts to reduce costs, improve inventory management, and boost its customer service. Graja also points to higher free cash flows generated in Q1 as the company's chairman Jeffrey Smith and CEO Tom Greco turn Advance Auto Parts into a more efficiently run firm. The analyst notes that the signs of operating improvement have also led him to increase his target enterprise value to EBIT valuation multiple to 15-times from 14-times.
06/22/18
UBSW
06/22/18
NO CHANGE
Target $160
UBSW
Buy
Advance Auto Parts price target raised to $160 from $130 at UBS
UBS analyst Michael Lasser raised his price target on Advance Auto Parts to $160 from $130. The analyst believes optimizing its distribution network is a significant portion of the $750M in gross savings it expects to achieve over the next three years. He believes it will pave the way to unlock more substantial savings in 2019 and beyond. Lasser reiterated his Buy rating on Advance Auto Parts shares.
07/12/18
RBCM
07/12/18
NO CHANGE
Target $154
RBCM
Outperform
Advance Auto Parts price target raised to $154 from $133 at RBC Capital
RBC Capital analyst Scot Ciccarelli raised his price target on Advance Auto Parts to $154 and kept his Outperform rating. The analyst says his deep dive analysis indicates that the company has "conservatively 300-450 bps of EBIT margin expansion potential", but needs to improve its sales productivity to fully unlock its earnings power, given that its sales per store metrics have been "stagnant since 2013".
06/29/18
BOFA
06/29/18
NO CHANGE
Target $330
BOFA
Buy
O'Reilly can take AutoZone share and withstand Amazon threat, says BofA/Merrill
BofA/Merrill analyst Elizabeth Suzuki is most positive on O'Reilly Automotive (ORLY) in her broader research note on the auto parts retail industry, saying the anticipated repair arc in the U.S. vehicle population favors companies with more exposure to "do it for me" like O'Reilly, Advance Auto Parts (AAP), and Genuine Parts (GPC) rather than "do it yourself" like AutoZone (AZO). The analyst sees Advance Auto Parts pricing in a more optimistic outlook while losing market share and underperforming on margins, rating the company at Underperform with a price target of $103. Suzuki states that Genuine Parts is also constrained by pricing headwinds, rating the company at Neutral with a $105 price target. The analyst likes O'Reilly's expected pace of new store growth, above-average operating margins, and its deepest relative moat through its developed distribution network against a potential threat of entry into the retail auto parts space by Amazon (AMZN), rating the company at Buy with a price target of $330.
VIPS Vipshop
$7.69

-1.29 (-14.37%)

08/14/18
SBSH
08/14/18
DOWNGRADE
SBSH
Sell
Vipshop downgraded to Sell from Buy at Citi
Citi analyst Alicia Yap downgraded Vipshop to Sell from Buy and cut its price target to $8 from $17 citing declining margins and decelerating growth.
08/14/18
DAIW
08/14/18
DOWNGRADE
DAIW
Underperform
Vipshop downgraded to Underperform from Neutral at Daiwa
06/26/18
LYON
06/26/18
UPGRADE
LYON
Outperform
Vipshop upgraded to Outperform from Underperform at CLSA
CLSA analyst Man Ho Lam upgraded Vipshop to Outperform following recent weakness in shares citing valuation. The analyst believes further downside is limited and sees potential upside from improved cooperation with Tencent-JD in 2H 2018.
07/11/18
GSCO
07/11/18
DOWNGRADE
Target $13.1
GSCO
Neutral
Vipshop downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Ronald Keung downgraded Vipshop to Neutral from Buy citing what he views as "fierce competition" and near-term risk to consensus earnings estimates as management steps up its marketing spending on attracting new users. Given his view that the cost of attracting new users will drag on margins for the coming quarters, Keung lowered his price target on Vipshop shares to $13.10 from $19.20.
SWCH Switch
$10.62

-3.34 (-23.93%)

08/14/18
JEFF
08/14/18
NO CHANGE
Target $12
JEFF
Hold
Switch price target lowered to $12 from $15 at Jefferies
Jefferies analyst Scott Goldman lowered his price target for Switch to $12 saying the magnitude of the guidance cut is surprising, and implies virtually no incremental growth in the second half of 2018. The analyst is inclined to believe the outlook is conservative, but adds that "visibility is weak and the track record spotty." He maintains a Hold rating on shares of Switch.
08/14/18
08/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Chubb (CB) downgraded to Sell from Hold at Deutsche Bank with analyst Joshua Shanker saying the company's recent quarterly results show that Chubb, post-merger, is unable to grow its business at the levels of its peers. 2. Switch (SWCH) was downgraded to Market Perform from Outperform at Raymond James, to Neutral from Overweight at JPMorgan, and to Neutral from Buy at BTIG. 3. Urban Outfitters (URBN) downgraded to Neutral from Outperform at Baird with analyst Mark Altschwager citing valuation. 4. Premier (PINC) downgraded to Hold from Buy at Canaccord with analyst Richard Close citing its quarter-to-date outperformance. 5. Parker-Hannifin (PH) downgraded to Hold from Buy at Argus with analyst John Eade saying that while the company's recent Q4 results topped expectations, management's outlook for FY19 was worse than expected. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/14/18
08/14/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. CREDIT SUISSE INITIATES CASINO STOCKS: Credit Suisse analyst Cameron McKnight initiated Gaming and Leisure Properties (GLPI), VICI Properties (VICI), and PlayAGS (AGS) with an Outperform, Las Vegas Sands (LVS), Wynn Resorts (WYNN), MGM Growth (MGP), and International Game (IGT) with a Neutral, as well as Scientific Games (SGMS) with an Underperform. MORGAN STANLEY RAISES SALESFORCE PRICE TARGET TO $178 FROM $153: Morgan Stanley analyst Keith Weiss raised his price target for Salesforce (CRM) shares to $178 from $153 and maintained an Overweight rating. Weiss noted that unlocking data trapped in legacy systems via MuleSoft brings the company to the forefront of driving digital transformation for its customers and added that consensus expectations likely underestimate its growth potential as well as its improved track record in M&A. JEFFRIES SAYS "SIGNIFICANT SHAREHOLDER VALUE TO BE UNLOCKED" AT NIELSEN: Even following yesterday's 12% rally, there is "significant shareholder value to be unlocked" at Nielsen Holdings (NLSN), Jefferies analyst Surinder Thind told investors in a research note. Nielsen was also upgraded to Outperform from Neutral at Macquarie and to Equal Weight from Underweight at Barclays. Morgan Stanley analyst Toni Kaplan reiterated an Overweight rating and $26 price target on the stock. NOMURA RAISES PRICE TARGET AFTER SQUARE CASH APP SURPASSED PAYPAL'S VENMO IN JULY: Nomura Instinet analyst Dan Dolev raised his price target for Square (SQ) to $86 from $82 after his firm's July payments app tracker showed cumulative Square Cash App downloads surpassed PayPal's (PYPL) Venmo for the first time. SWITCH DOWNGRADED AT MULTIPLE FIRMS: Switch (SWCH) was downgraded to Market Perform from Outperform at Raymond James, to Neutral from Overweight at JPMorgan, and to Neutral from Buy at BTIG. Switch shares are down about 25% in morning trading.
08/14/18
BMOC
08/14/18
NO CHANGE
Target $14
BMOC
Outperform
Switch price target lowered to $14 from $20 at BMO Capital
BMO Capital analyst Tim Long lowers his price target on Switch to $14 after its Q2 earnings miss and reduced FY18 outlook, saying that the lack of visibility is weighing on the stock. Long keeps his Outperform rating however, noting that Switch's total contract value remained "impressive". The analyst also states that its new valuation implies a 15% discount to the Data Center REIT average, which is too low after the company's expectations have been reset.
AMR Alta Mesa Resources
$4.98

-1.1 (-18.09%)

04/05/18
STFL
04/05/18
INITIATION
Target $13
STFL
Buy
Alta Mesa Resources initiated with a Buy at Stifel
Stifel analyst Derrick Whitfield started Alta Mesa Resources with a Buy rating and $13 price target, as he believes the stock has been unfairly punished for non-related industry developments in the STACK. He expects investor perception on the STACK to improve and thinks the IPO of Kingfisher Midstream has the potential to re-rate Alta Mesa, Whitfield tells investors.
07/30/18
07/30/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ADMA Biologics (ADMA) initiated with a Buy at Chardan. 2. Alta Mesa Resources (AMR) initiated with a Buy at Guggenheim. 3. Azure Power (AZRE) initiated with an Outperform at JMP Securities. 4. Exela Technologies (XELA) initiated with a Buy at Nomura Instinet. 5. Wix.com (WIX) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/18
GSCO
07/10/18
INITIATION
Target $8.25
GSCO
Buy
Alta Mesa Resources initiated with a Buy at Goldman Sachs
Goldman Sachs started Alta Mesa Resources with a Buy rating and $8.25 price target. The firm believes the company's assets and growth are underappreciated at current valuation levels.
07/30/18
GUGG
07/30/18
INITIATION
Target $10
GUGG
Buy
Alta Mesa Resources initiated with a Buy at Guggenheim
Guggenheim analyst Subash Chandra initiated Alta Mesa Resources with a Buy and $10 price target.

TODAY'S FREE FLY STORIES

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change  »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change  »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change at Goldman Sachs »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/16/18
12/16
04:55
12/16/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.